Patent · US3692910A · A · US
Benzylisoquinolinic solutions and method of making the same
- (11) Publication number
- US3692910A
- (22) Filing date
- 1968-09-05
- (30) Priority date
- 1967-09-07
- (43) Publication date
- 1972-09-19
- (45) Date of grant
- 1972-09-19
- (51) IPC
- A61K 31/485; A61K 47/18
- (52) CPC
- A61K Preparations for medical, dental or toiletry purposes: 47/18, 31/485, 9/0019
- (72) Inventors
- Umberto Laguzzi
- (54) Title
- Benzylisoquinolinic solutions and method of making the same
- (57) Abstract
Benzylisoquinolinic solutions and particularly injectable solutions are produced by forming an intimate mixture of appropriate proportions of benzylisoquinolinic compounds, aliphatic alkanol amines which serve as solubilizing agent, a buffer selected from salts of organic acids with alkanol amines or N-methylglucamine, and the proportion of water required to obtain the final solution of the desired concentration of the benzylisoquinolinic compound.
- Full text
- View on Google Patents
Claims (11)
- The method of claim 1 wherein said member (c) is added in an amount whereby said aqueous solution is a pH of from 7.8-8.5.
- The method of claim 1 wherein said member (b) additionally contains an anti-oxidant.
- A composition comprising an aqueous solution of polyhydroxybenzylisoquinoline or an ester thereof produced by the process of claim 1.
- A composition according to claim 4 additionally containing an anti-oxidant.
- A compoisition according to claim 5 wherein said anti-oxidant is at least one member selected from the group consisting of butylhydroxyanisol, nordihydroguaiantico and propylgallate.
- A composition according to claim 4 wherein said member (c) is a salt with an organic acid selected from the group consisting of citric acid, tartaric acid, succinic acid and maleic acid.
- A composition according to claim 7 wherein said member (c) is N-methylglucamine citrate.
- A composition according to claim 4 wherein said aqueous solution has a pH of between 7.8 and 8.5.
- A composition according to claim 4 wherein said member (b) is present in an amount of 100-200 mg/ml.
- A composition according to claim 4 wherein said polyhydroxybenzylisoquinoline is a member selected from the group consisting of 1-(3,4 dioxybenzyl)-6,7 dioxyisoquinoline and 1-(3, 4 dibenzoyloxybenzyl)-6,7 dibenzoyloxyisoquinoline.
- A pharmaceutical injectible solution comprising a composition according to claim 4 in dosage unit form.
Record as JSON
{
"publication_number": "US3692910A",
"country": "US",
"kind": "A",
"title": "Benzylisoquinolinic solutions and method of making the same",
"abstract": "Benzylisoquinolinic solutions and particularly injectable solutions are produced by forming an intimate mixture of appropriate proportions of benzylisoquinolinic compounds, aliphatic alkanol amines which serve as solubilizing agent, a buffer selected from salts of organic acids with alkanol amines or N-methylglucamine, and the proportion of water required to obtain the final solution of the desired concentration of the benzylisoquinolinic compound.",
"claims": [
"2. The method of claim 1 wherein said member (c) is added in an amount whereby said aqueous solution is a pH of from 7.8-8.5.",
"3. The method of claim 1 wherein said member (b) additionally contains an anti-oxidant.",
"4. A composition comprising an aqueous solution of polyhydroxybenzylisoquinoline or an ester thereof produced by the process of claim 1.",
"5. A composition according to claim 4 additionally containing an anti-oxidant.",
"6. A compoisition according to claim 5 wherein said anti-oxidant is at least one member selected from the group consisting of butylhydroxyanisol, nordihydroguaiantico and propylgallate.",
"7. A composition according to claim 4 wherein said member (c) is a salt with an organic acid selected from the group consisting of citric acid, tartaric acid, succinic acid and maleic acid.",
"8. A composition according to claim 7 wherein said member (c) is N-methylglucamine citrate.",
"9. A composition according to claim 4 wherein said aqueous solution has a pH of between 7.8 and 8.5.",
"10. A composition according to claim 4 wherein said member (b) is present in an amount of 100-200 mg/ml.",
"11. A composition according to claim 4 wherein said polyhydroxybenzylisoquinoline is a member selected from the group consisting of 1-(3,4 dioxybenzyl)-6,7 dioxyisoquinoline and 1-(3, 4 dibenzoyloxybenzyl)-6,7 dibenzoyloxyisoquinoline.",
"12. A pharmaceutical injectible solution comprising a composition according to claim 4 in dosage unit form."
],
"cpc": [
"A61K 47/18",
"A61K 31/485",
"A61K 9/0019"
],
"ipc": [
"A61K 31/485",
"A61K 47/18"
],
"inventors": [
"Umberto Laguzzi"
],
"filing_date": "1968-09-05",
"publication_date": "1972-09-19",
"grant_date": "1972-09-19",
"priority_date": "1967-09-07",
"application_number": "US-3692910D-A",
"family_id": "11165135",
"cited_by_count": 5
}
Record 7,948 of 8,000 in Patents full text (MLC-0201). Request the full dataset.